Physician profile
Raul Mendelovici
NPI 1205834363
$16,421.73
in general payments reported to CMS, 2019-2025
6 companies · $96.58 in 2025
The $96.58 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,276 · 2020: $10.99 · 2021: $80.25 · 2022: $8,204 · 2023: $275 · 2024: $2,479 · 2025: $96.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,125 · Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,125.00 |
| Food and Beverage | $725.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $16,168.91 | 2019-2024 | Solyx Sis System, Advantage System, Upsylon |
| Dentsply Ih Ab | $80.72 | 2023-2025 | Lofric, Lofric |
| Abbvie INC. | $60.02 | 2024-2025 | |
| Axonics, INC. | $54.82 | 2020-2024 | Axonics |
| Medtronic, INC. | $29.57 | 2023 | Interstim |
| Coloplast Corp | $27.69 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Mendelovici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.